Insulin inhibits extracellular regulated kinase 1/2 phosphorylation in a phosphatidylinositol 3-kinase (PI3) kinase-dependent manner in neuro2a cells

Journal of Neurochemistry

Volumn 86, Issue 1, 2003, Pages 86-91

  Van der Heide, L P ^a   Hoekman, M F M ^a   Biessels, G J ^a   Gispen, W H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Insulin; Intracellular; Neuron; Resistance; Signalling

Indexed keywords

INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; DESENSITIZATION; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; INSULIN; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROBLASTOMA; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0037632930     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01828.x     Document Type: Article

References (21)

1. Alessi D. R. and Downes C. P. (1998) The role of PI3-kinase in insulin action. Biochim. Biophys. Acta 1436, 151-164.
2. Begum N. and Ragolia L. (2000) High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation. Am. J. Physiol. Cell Physiol. 278, C81-C91.
3. Coffer P. J., Jin J. and Woodgett J. R. (1998) Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335, 1-13.
4. Duelli R., Schrock H., Kuschinsky W. and Hoyer S. (1994) Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int. J. Dev. Neurosci. 12, 737-743.
5. Eldar-Finkelman H. and Krebs E. G. (1997) Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc. Natl Acad. Sci. USA 94, 9660-9664.
6. Kumagai A. K. (1999) Glucose transport in brain and retina: implications in the management and complications of diabetes. Diabetes Metab. Res. Rev. 15, 261-273.
7. Lee A. V., Gooch J. L., Oesterreich S., Guler R. L. and Yee D. (2000) Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3′-kinase inhibition. Mol. Cell. Biol. 20, 1489-1496.
8. Liu Y. F., Paz K., Herschkovitz A., Alt A., Tennenbaum T., Sampson S. R., Ohba M., Kuroki T., LeRoith D. and Zick Y. (2001) Insulin stimulates PKCzeta-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J. Biol. Chem. 276, 14459-14465.
9. Ravichandran L. V., Esposito D. L., Chen J. and Quon M. J. (2001) Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J. Biol. Chem. 276, 3543-3549.
10. Rommel C., Clarke B. A., Zimmermann S., Nunez L., Rossman R., Reid K., Moelling K., Yancopoulos G. D. and Glass D. J. (1999) Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741.
11. Rui L., Fisher T. L., Thomas J. and White M. F. (2001) Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J. Biol. Chem. 276, 40362-40367.
12. Ruiz-Hidalgo M. J., Gubina E., Tull L., Baladron V. and Laborda J. (2002) dlk modulates mitogen-activated protein kinase signaling to allow or prevent differentiation. Exp. Cell Res. 274, 178-188.
13. Sauter A., Goldstein M., Engel J. and Ueta K. (1983) Effect of insulin on central catecholamines. Brain Res. 260, 330-333.
14. Schulingkamp R. J., Pagano T. C., Hung D. and Raffa R. B. (2000) Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci. Biobehav. Rev. 24, 855-872.
15. Schwartz M. W., Baskin D. G., Kaiyala K. J. and Woods S. C. (1999) Model for the regulation of energy balance and adiposity by the central nervous system. Am. J. Clin. Nutr. 69, 584-596.
16. Shepherd P. R., Nave B. T., Rincon J., Haigh R. J., Foulstone E., Proud C., Zierath J. R., Siddle K. and Wallberg-Henriksson H. (1997) Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism. Diabetologia 40, 1172-1177.
17. Sweatt J. D. (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76, 1-10.
18. Taha C. and Klip A. (1999) The insulin signaling pathway. J. Membr. Biol. 169, 1-12.
19. White M. F. (1997) The insulin signalling system and the IRS proteins. Diabetologia 40, S2-S17.
20. Zhao W. Q. and Alkon D. L. (2001) Role of insulin and insulin receptor in leaming and memory. Mol. Cell. Endocrinol. 177, 125-134.
21. Zimmermann S. and Moelling K. (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286, 1741-1744.